Samsung Medical Center
Chondrosarcoma treatment cost in the Republic of Korea is influenced by the disease stage and begins with a complex diagnosis of sarcoma ranging from $1,900 to $3,400. Primary treatments such as proton-beam therapy run from $22,000 to $45,000. Patients typically save 30% to 50% compared to the United States. Key medical hubs for this procedure include Seoul and Incheon.
Typical Chondrosarcoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: Advanced cases requiring high-precision radiation benefit most from centers like Samsung Medical Center. This facility utilizes IGRT and Novalis technologies for complex tumor targeting. For patients prioritizing safety, Seoul National University Bundang Hospital uses the "BESTcare" system to eliminate medical errors. International patients often choose centers like Severance Hospital for their JCI-accredited multidisciplinary oncology programs. These university hospitals provide presidential-standard care with robust diagnostic capabilities.
| Republic of Korea | Turkey | Austria | |
| Proton-beam therapy | from $22,000 | from $70,000 | from $80,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Proton therapy for prostate cancer | - | from $30,000 | from $80,000 |
| Proton therapy for breast cancer | - | from $30,000 | from $55,000 |
| Bone resection | - | from $8,000 | from $25,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Chondrosarcoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chondrosarcoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chondrosarcoma treatment journey.
Prof. Sung Hoon Noh is the Director of the Yonsei Cancer Center and specializes in advanced gastric cancer treatment. He has served in various leadership roles in various cancer and surgical societies and has been awarded multiple accolades for his outstanding work in surgery.
Dr. X is a highly experienced surgeon, currently serving as the Director of the Training and Education Committee of the Korean Surgical Society, the Director of Information Technology Committee of the Korean Society of Coloproctology, the Director of Surgical Affairs Board of the Korean Society of Gastroenterology, and the Vice President of the Korean Association of Robotic Surgeons. He has held several surgical demonstrations and trainings in various countries and holds a Ph.D. and M.S. in Surgery from Korea University and a Doctor of Medicine from the College of Medicine at Korea University.